Nils-Olof Johansson
Technik-/Wissenschafts-/F&E-Leiter bei Carmeda AB
Profil
Nils-Olof Johansson joined Carmeda AB in 2001and currently serves as Director of Medical Affairs.
He is Chief Scientific Officer and Scientific Director of CMC Contrast AB and a Director of Clavis Pharma AS.
Prior to joining Carmeda, Dr. Johansson was Head of the Haematology Division for Kabi AB from 1977 to 1991.
Previously, he was Managing Director of Recip AB and a Member of the Nycomed Research Council.
Dr. Johansson received an MD from the Karolinska Institutet and Pharmaceutical degree from the Pharmaceutical Institute in Stockholm.
Aktive Positionen von Nils-Olof Johansson
| Unternehmen | Position | Beginn |
|---|---|---|
Carmeda AB
 Carmeda AB Pharmaceuticals: MajorHealth Technology Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 |
Ausbildung von Nils-Olof Johansson
| Karolinska Institutet | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Carmeda AB
Carmeda AB Pharmaceuticals: MajorHealth Technology Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden. | Health Technology |
